FDA Approved: TRIKAFTA — Supplemental Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

The FDA approved Vertex's supplemental application for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor), a cystic fibrosis TRIKAFTA combination therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

SUPPL AP for TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)